Retraction to: npj Vaccines https://doi.org/10.1038/s41541-021-00424-2, published online 10 January 2022
The Editor-in-Chief has retracted this article because of concerns regarding figures presented in this work. These concerns call into question the article’s overall scientific soundness. An investigation conducted after its publication discovered that panel α-synuclein TG PV-1950D, Male Hippocamp in Figure 7a appears to overlap, when rotated, with panel α-synuclein TG PV-1950D, Female Hippocamp in Figure 7c. These panels represent tissues taken from different animals. The Authors provided some raw data on request from the Publisher. However, this was insufficient to satisfy the concerns raised. In light of previous concerns involving figures presented in this article, the Editor-in-Chief therefore no longer has confidence in the integrity of the research presented in this article.
Michael G. Agadjanyan has stated on behalf of Armine Hovakimyan, Karen Zagorski, Tatevik Antonyan, Gor Chailyan, Anahit Ghochikyan, Irina Petrushina, Mathew Blurton-Jones, David H. Cribbs, and Hayk Davtyan that they disagree with the retraction. Eliezer Masliah disagrees with the retraction. Jonathan Hasselmann agrees with the retraction. The Publisher was unable to contact Anthony Adame. Changyoun Kim, Michiyo Iba, and Marcell Szabo have not replied to correspondence from the Publisher. The Publisher has been informed that Edward Rockenstein has passed away.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Kim, C., Hovakimyan, A., Zagorski, K. et al. Retraction Note: Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies. npj Vaccines 10, 47 (2025). https://doi.org/10.1038/s41541-025-01102-3
Published:
Version of record:
DOI: https://doi.org/10.1038/s41541-025-01102-3
